2m 2m 2m 2m 2m 2m 2m
VTV THERAP-A (VTVT)
NASDAQ
$31.98+$0.01 (+0.03%)
Price as of Sep 11, 2026 7:30 PM EDT- $126.4MMarket Cap
- 61.79%1-Year Change
- BiotechnologyIndustry
VTV THERAP-A (VTVT)
$31.98+$0.01 (+0.03%)
VTVT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $31.97 | ||
Change | +$0.11 (+0.35%) | ||
Open | $32.24 | ||
High | $32.54 | ||
Low | $31.29 | ||
Previous Close | $31.86 | ||
Volume | 13,723 | ||
30-Day Average Volume | 48,739 | ||
1-Week Change | -4.14% | ||
1-Month Change | -3.24% | ||
1-Year Change | 61.79% | ||
3-Year Change | 65.13% | ||
5-Year Change | -55.60% | ||
Fundamentals | |||
Shares Outstanding | 4.0M | ||
Total Assets | $87.6M | ||
Market Cap | $126.4M | ||
Enterprise Value | $39.8M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$13.1M | ||
Free Cash Flow | -$11.4M | ||
EBIT | -$13.1M | ||
EBITDA | -$13.1M | ||
Net Working Capital | $80.6M | ||
EPS | -$1.05 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -30 | ||
PEG | 0 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 40 | ||
Last Split Date | 11/21/2023 | ||
Earnings & Revenue